Skip to main content
logo
Sanofi logo
Sanofi (SNY)
NASDAQ: SNY · Real-Time Price · USD
40.07
-0.16 (-0.40%)
At close: Oct 9, 2026, 4:00 PM EDT
40.24
+0.17 (0.42%)
After-hours: Oct 9, 2026, 7:52 PM EDT

Sanofi Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Operating Revenue
11,59710,50911,30312,4349,9949,895-13,438-10,464-11,9649,96510,22210,72512,48210,1169,6749,99410,432
Other Revenue
703735902736741711-719-654-734623641731656626379421397
Revenue
12,30011,24412,20513,17010,73510,606-14,157-11,118-12,69810,58810,86311,45613,13810,74210,05310,41510,829
Revenue Growth (YoY)
14.58%6.02%--6.97%--4.61%-11.49%-2.35%--3.35%-1.43%8.06%9.99%21.32%18.76%13.13%6.97%9.62%
Cost of Revenue
2,8893,0563,6303,4122,9922,889-4,085-3,439-3,8413,2633,0793,7313,8313,2472,8803,4723,238
Gross Profit
9,4118,1888,5759,7587,7437,717-10,072-7,679-8,8577,3257,7847,7259,3077,4957,1736,9437,591
Selling, General & Admin
2,4922,3272,8192,2912,3212,222-2,681-2,605-2,5792,6162,6072,9422,6442,6002,3792,8022,267
Research & Development
2,2331,7472,2911,8341,9091,808-1,852-1,719-1,6631,6301,5631,8231,7361,6581,4891,5861,443
Amortization of Goodwill & Intangibles
552535538461378399-479-562-562546489457460461449420385
Other Operating Expenses
1,5471,3301,1871,3881,423864-981-761-576987304842-185935283895293
Operating Expenses
6,8245,9396,8355,9746,0315,293-5,993-5,647-5,3805,7794,9636,0644,6555,6544,6005,7034,388
Operating Income
2,5872,2491,7403,7841,7122,424-4,079-2,032-3,4771,5462,8211,6614,6521,8412,5731,2403,203
Interest Expense
-153-138--227-62-154--265--253--318-60-168-102-103-88-88-113-87
Interest & Investment Income
6460791147286-133-151-14310016187521310-2
Earnings From Equity Investments
-911-238-24342-78--37-65-641237283018-5
Currency Exchange Gain (Loss)
-3-2-1--------3--4--1-2-
Other Non Operating Income (Expenses)
-91-40122--24-59-------73-37-25-70-
EBT Excluding Unusual Items
2,3952,1421,7053,6691,7422,339-4,025-1,893-3,3671,4462,8261,6824,6081,8182,5251,2173,113
Merger & Restructuring Charges
-572-201-662-172-325-105--256--740--259-312-240-173-374-620-175-330-167
Gain (Loss) on Sale of Investments
---9-----------1---3-
Gain (Loss) on Sale of Assets
203386685344----199--413-655-288-418-
Asset Writedown
-1,031--2,013-18-185-25--180-17--4--151,901-1,586-82-5-151
Legal Settlements
-95--255--57-----79--88-88------
Other Unusual Items
-723513-56-52-9--8-20--383-151232-2141145
Pretax Income
8282,014-1,1553,5081,4672,200-3,581-1,310-3,1011,7182,4684,0782,6801,3832,3491,4072,952
Income Tax Expense
451420-348680230481-737-164-563271459910601163332267609
Earnings From Continuing Operations
3771,594-8072,8281,2371,719-2,844-1,146-2,5381,4472,0093,1682,0791,2202,0171,1402,343
Earnings From Discontinued Operations
-2613-202,707174--------------
Net Income to Company
3771,620-7942,8083,9441,893-2,844-1,146-2,5381,4472,0093,1682,0791,2202,0171,1402,343
Minority Interest in Earnings
-34-6-7-6-4-21--29--13--13-12-14-57-3-45-8-10-26
Net Income
3431,614-8012,8023,9401,872-2,815-1,133-2,5251,4351,9953,1112,0761,1752,0091,1302,317
Net Income to Common
3431,614-8012,8023,9401,872-2,815-1,133-2,5251,4351,9953,1112,0761,1752,0091,1302,317
Net Income Growth (YoY)
-91.29%-13.78%--0.46%-65.22%-11.48%--43.21%-21.63%22.13%-0.70%175.31%-10.40%-1.92%28.29%6.50%18.70%
Shares Outstanding (Basic)
1,1971,2041,2131,2181,2171,234-1,253-1,249-1,2531,2511,2491,2541,2541,2511,2491,2551,255
Shares Outstanding (Diluted)
1,1971,2041,2131,2181,2171,234-1,253-1,249-1,2531,2511,2491,2541,2541,2511,2491,2551,255
Shares Change (YoY)
-1.68%-2.41%--2.79%--1.19%--0.02%--0.04%--0.02%-0.02%0.01%-0.07%-0.08%-0.88%-0.01%-0.02%-0.10%
EPS (Basic)
0.291.34-0.662.303.241.52-2.25-0.91-2.011.151.602.481.660.941.610.901.85
EPS (Diluted)
0.281.34-0.662.303.231.52-2.25-0.91-2.011.141.602.481.660.941.610.901.85
EPS Growth (YoY)
-91.20%-11.66%-2.39%-67.22%-11.50%--43.19%-21.66%21.70%-0.70%175.50%-10.33%-0.91%28.30%6.52%18.81%

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Free Cash Flow
2,0781,6831,6834,5956172,093--------------
Free Cash Flow Per Share
1.741.401.393.770.511.70--------------
Dividend Per Share
--4.120-----------3.560---3.330-
Dividend Growth (YoY)
--------------6.91%---4.06%-
Gross Margin
76.51%72.82%70.26%74.09%72.13%72.76%-71.14%-69.07%-69.75%69.18%71.66%67.43%70.84%69.77%71.35%66.66%70.10%
Operating Margin
21.03%20.00%14.26%28.73%15.95%22.86%-28.81%-18.28%-27.38%14.60%25.97%14.50%35.41%17.14%25.59%11.91%29.58%
Profit Margin
2.79%14.35%-6.56%21.28%36.70%17.65%-19.88%-10.19%-19.89%13.55%18.37%27.16%15.80%10.94%19.98%10.85%21.40%
Free Cash Flow Margin
16.89%14.97%13.79%34.89%5.75%19.73%--------------
EBITDA
3,8262,7843,4904,1972,5333,172-4,909-2,862-4,2332,4583,5772,4175,3242,7083,2451,9123,925
EBITDA Margin
31.11%24.76%28.59%31.86%23.60%29.91%-34.67%-25.74%-33.34%23.21%32.93%21.10%40.52%25.20%32.27%18.35%36.24%
D&A For EBITDA
1,2395351,750412.67821748699829.5806.5829.5738.75756911.5756756671.5866.5671.5671.5721.75
EBIT
2,5872,2491,7403,7841,7122,424-4,079-2,032-3,4771,5462,8211,6614,6521,8412,5731,2403,203
EBIT Margin
21.03%20.00%14.26%28.73%15.95%22.86%-28.81%-18.28%-27.38%14.60%25.97%14.50%35.41%17.14%25.59%11.91%29.58%
Effective Tax Rate
54.47%20.85%-19.38%15.68%21.86%-20.58%-12.52%-18.15%15.77%18.60%22.31%22.43%11.79%14.13%18.98%20.63%
SEC Filings: 10-K · 10-Q